Print
Celgene
(
CELG
) (
JOBS
) Investors Struggle with Confusing Data
12/9/2009 7:07:57 AM
Reuters -- Celgene Corp (CELG.O) investors were struggling on Tuesday to sort through confusing results from a key trial of the company's cancer drug Revlimid.